Sustained complete remission of recurrent acute myeloid leukaemia with a single dose of gemtuzumab ozogamicin and low-dose interleukin-2 maintenance

被引:0
|
作者
MP Radsak
HR Salih
M Sökler
L Kanz
C Denzlinger
机构
[1] University of Tübingen,Department of Haematology/Oncology
[2] Medical School,undefined
来源
Leukemia | 2002年 / 16卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1870 / 1871
页数:1
相关论文
共 50 条
  • [1] Sustained complete remission of recurrent acute myeloid leukaemia with a single dose of gemtuzumab ozogamicin and low-dose interleukin-2 maintenance
    Radsak, MP
    Salih, HR
    Sökler, M
    Kanz, L
    Denzlinger, C
    [J]. LEUKEMIA, 2002, 16 (09) : 1870 - 1871
  • [2] MAINTENANCE WITH LOW-DOSE CYTARABINE FOR ACUTE MYELOID-LEUKEMIA IN COMPLETE REMISSION
    ARCHIMBAUD, E
    ANGLARET, B
    THOMAS, X
    JAUBERT, J
    SEBBAN, C
    GUYOTAT, D
    FIERE, D
    [J]. ANNALS OF HEMATOLOGY, 1992, 65 (02) : 71 - 74
  • [3] Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission
    Mao, Chen
    Fu, Xiao-Hong
    Yuan, Jin-Qiu
    Yang, Zu-Yao
    Huang, Ya-Fang
    Ye, Qian-Ling
    Wu, Xin-Yin
    Hu, Xue-Feng
    Zhai, Zhi-Min
    Tang, Jin-Ling
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (11):
  • [4] Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study
    Poloni, Antonella
    Capelli, Debora
    Trappolini, Silvia
    Costantini, Benedetta
    Montanari, Mauro
    Gini, Guido
    Scortechini, Ilaria
    Mancini, Giorgia
    Discepoli, Giancarlo
    Leoni, Pietro
    Olivieri, Attilio
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (01) : 119 - 121
  • [5] Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia
    Hallner, Alexander
    Aurelius, Johan
    Thoren, Fredrik Bergh
    Sander, Frida Ewald
    Brune, Mats
    Hellstrand, Kristoffer
    Martner, Anna
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (03) : 279 - 280
  • [6] Successful treatment with low-dose gemtuzumab ozogamicin in combination chemotherapy followed by stem cell transplantation for children with refractory acute myeloid leukaemia
    Yoshida, Nao
    Sakaguchi, Hirotoshi
    Matsumoto, Kimikazu
    Kato, Koji
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (05) : 666 - 668
  • [7] Sustained molecular remission after low dose gemtuzumab-ozogamicin in elderly patients with advanced acute promyelocytic leukemia
    Breccia, Massimo
    Cimino, Giuseppe
    Diverio, Daniela
    Gentilini, Fabiana
    Mandelli, Franco
    Lo Coco, Francesco
    [J]. HAEMATOLOGICA, 2007, 92 (09) : 1273 - 1274
  • [8] Successful treatment with low-dose gemtuzumab ozogamicin-combined chemotherapy followed by unrelated stem cell transplantation for children with refractory acute myeloid leukaemia
    Yoshida, N.
    Sakaguchi, H.
    Matsumoto, K.
    Kato, K.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S150 - S150
  • [9] LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTERLEUKIN-2 FOR MALIGNANT-MELANOMA
    MITCHELL, MS
    KEMPF, RA
    HAREL, W
    SHAU, H
    BOSWELL, WD
    LIND, S
    DEAN, G
    MOORE, J
    BRADLEY, EC
    [J]. BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1989, 65 (01) : 128 - 144
  • [10] Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid
    Martini, Vincenza
    Minotti, Clara
    Breccia, Massimo
    De Angelis, Gioia
    Buffolino, Sonia
    Mariella, Montano
    Lo-Coco, Francesco
    Avvisati, Giuseppe
    Cimino, Giuseppe
    [J]. ANNALS OF HEMATOLOGY, 2007, 86 (04) : 295 - 297